137 related articles for article (PubMed ID: 18459830)
1. A potential role of the heparan sulfate in the hepatitis C virus attachment.
Heo TH
Acta Virol; 2008; 52(1):7-15. PubMed ID: 18459830
[TBL] [Abstract][Full Text] [Related]
2. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
Akula SM; Pramod NP; Wang FZ; Chandran B
Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
[TBL] [Abstract][Full Text] [Related]
3. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
[TBL] [Abstract][Full Text] [Related]
6. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence.
Hulst MM; van Gennip HG; Vlot AC; Schooten E; de Smit AJ; Moormann RJ
J Virol; 2001 Oct; 75(20):9585-95. PubMed ID: 11559790
[TBL] [Abstract][Full Text] [Related]
7. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 8 interaction with target cells involves heparan sulfate.
Akula SM; Wang FZ; Vieira J; Chandran B
Virology; 2001 Apr; 282(2):245-55. PubMed ID: 11289807
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
Jiang J; Cun W; Wu X; Shi Q; Tang H; Luo G
J Virol; 2012 Jul; 86(13):7256-67. PubMed ID: 22532692
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.
Techaarpornkul S; Collins PL; Peeples ME
Virology; 2002 Mar; 294(2):296-304. PubMed ID: 12009871
[TBL] [Abstract][Full Text] [Related]
12. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.
Barth H; Schnober EK; Zhang F; Linhardt RJ; Depla E; Boson B; Cosset FL; Patel AH; Blum HE; Baumert TF
J Virol; 2006 Nov; 80(21):10579-90. PubMed ID: 16928753
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
14. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.
Barth H; Schafer C; Adah MI; Zhang F; Linhardt RJ; Toyoda H; Kinoshita-Toyoda A; Toida T; Van Kuppevelt TH; Depla E; Von Weizsacker F; Blum HE; Baumert TF
J Biol Chem; 2003 Oct; 278(42):41003-12. PubMed ID: 12867431
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
16. Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein.
Heo TH; Chang JH; Lee JW; Foung SK; Dubuisson J; Kang CY
J Immunol; 2004 Jul; 173(1):446-55. PubMed ID: 15210804
[TBL] [Abstract][Full Text] [Related]
17. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate.
Azab W; Tsujimura K; Maeda K; Kobayashi K; Mohamed YM; Kato K; Matsumura T; Akashi H
Virus Res; 2010 Jul; 151(1):1-9. PubMed ID: 20236610
[TBL] [Abstract][Full Text] [Related]
19. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
20. Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors.
Chen PC; Chuang PK; Chen CH; Chan YT; Chen JR; Lin SW; Ma C; Hsu TL; Wong CH
ACS Chem Biol; 2014 Jul; 9(7):1437-43. PubMed ID: 24766301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
